RepliCel Life Sciences Revenue Q/Q
What is the Revenue Q/Q of RepliCel Life Sciences?
The Revenue Q/Q of RepliCel Life Sciences, Inc. is 0.00%
What is the definition of Revenue Q/Q?
Quarterly revenue growth, year over year, is the increase of a company’s revenue compared to the performance in the corresponding quarter of a previous year expressed as a percentage.
quarterly growth yoy (year over year)
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenue Q/Q of companies in the Health Care sector on TSXV compared to RepliCel Life Sciences
What does RepliCel Life Sciences do?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Companies with revenue q/q similar to RepliCel Life Sciences
- Principal Inc has Revenue Q/Q of -0.04%
- BT plc has Revenue Q/Q of -0.02%
- BT Plc has Revenue Q/Q of -0.02%
- William Hill Plc has Revenue Q/Q of -0.01%
- Indian Exchange has Revenue Q/Q of -0.01%
- XPO Logistics Europe SA has Revenue Q/Q of -0.01%
- RepliCel Life Sciences has Revenue Q/Q of 0.00%
- Schroders Plc has Revenue Q/Q of 0.01%
- China XLX Fertiliser has Revenue Q/Q of 0.02%
- China LNG has Revenue Q/Q of 0.02%
- JPMorgan Chase & Co has Revenue Q/Q of 0.02%
- Qingdao Haier Biomedical Co has Revenue Q/Q of 0.03%
- Carrefour SA has Revenue Q/Q of 0.03%